Horizon to raise $50.8m to fund Duexis launch and Lodotra ambitions
This article was originally published in Scrip
Horizon Pharma plans to raise $50.8 million in a private placement of 14 million units at $3.62 each. One unit will be made up of one share of Horizon common stock and a warrant to purchase 0.25 shares at an exercise price of $4.31 per share. The financing, which is expected to close this week, will raise around $50.8 million.